Status:
NOT_YET_RECRUITING
Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19
Lead Sponsor:
University of Calgary
Conditions:
Long COVID Fatigue
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Individuals living with Long COVID often experiencing a degree of undue fatigue after physical or cognitive exertion secondary to the condition, timed post-exertional malaise 9PEM). This trial aims to...
Detailed Description
cognitive dysfunction, and post-exertional malaise are common complaints of those living with Post-COVID Condition (PCC), a sequelae of symptoms that persist beyond acute infection. Similar to other t...
Eligibility Criteria
Inclusion
- Experiencing symptoms at least 3 months after a COVID-19 diagnosis confirmed by positive polymerase chain reaction (PCR) test
- Experiencing post-exertional malaise, as per the DePaul Symptom Questionnaire
Exclusion
- Allergy or intolerance to creatine monohydrate or maltodextrin
- Supplemented with creatine in the past eight weeks
- orthopaedic injury or condition that would prevent exercise testing
- change in medication related to Long COVID symptom management in the past month.
Key Trial Info
Start Date :
July 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06992414
Start Date
July 2 2025
End Date
October 31 2026
Last Update
May 31 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.